SPRY
Ars Pharmaceuticals Inc
NASDAQ · Biotechnology
$10.03
+0.36 (+3.72%)
Open$9.87
Previous Close$9.67
Day High$10.05
Day Low$9.70
52W High$18.90
52W Low$6.66
Volume—
Avg Volume1.36M
Market Cap991.45M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+557.1% upside
Current
$10.03
$10.03
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 86.07M | 357.40M | 350.63M |
| Net Income | 7.72M | 35.24M | 44.72M |
| Profit Margin | 9.0% | 9.9% | 12.8% |
| EBITDA | 8.10M | 65.64M | 71.27M |
| Free Cash Flow | — | 46.75M | 30.69M |
| Rev Growth | — | +16.3% | -1.3% |
| Debt/Equity | — | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |